Two-Piece Floating Joint Replacement Device With A Rigid Backing Material

ABSTRACT

A two-part joint replacement device for replacing damaged soft joint tissue, such as a meniscus or cartilage tissue. In one form, the device may include a free floating soft joint tissue replacement component comprising a first tissue-interface surface shaped to engage a first anatomical (bone and/or cartilage) structure of a joint having damaged soft tissue. The device may also include a free floating rigid base component comprising a second tissue-interface surface shaped to engage a second anatomical (bone and/or cartilage) structure of the joint. The free floating soft joint tissue replacement component may be shaped to slidably interface with the rigid base component. In another form, the free floating soft joint tissue replacement component and the rigid base component are fixed together.

PRIORITY DATA

This application is a continuation of U.S. patent application Ser. No.16/047,759, filed on Jul. 27, 2018, issued as U.S. Pat. No. 10,835,381,which claims priority to and the benefit of U.S. Provisional PatentApplication No. 62/538,059, filed on Jul. 28, 2017, the entireties ofwhich are hereby incorporated by reference herein.

FIELD OF THE INVENTION

The disclosure generally relates to medical prosthetic devices andmethods. More specifically, the disclosure relates to prosthetic devicesthat replace at least part of the functionality of the natural softtissue, such as a meniscus or cartilage, at joint bearing surfaces.

BACKGROUND

A knee has two menisci, a lateral meniscus and a medial meniscus. Eachmeniscus is a crescent-shaped fibrocartilaginous tissue attached to thetibia at an anterior and a posterior horn. Damage to the meniscus cancause pain and arthritis. Further, damage to cartilage on the bearingsurfaces of the tibia and femur may lead to additional pain and maycause additional damage to the meniscus. Accordingly, current practicesfor treating patients with damaged knee cartilage are to perform a totalknee replacement. Alternatively, if the damaged cartilage is limited toone side of the knee, a unicompartmental knee replacement procedure maybe performed where the femur and tibia bones are milled off and implantsare inserted into both bones to perform the bearing function of theknee. In such a procedure, even though cartilage of only one of the bonesurfaces is damaged, both cartilage surfaces will be removed andreplaced with an artificial bearing surface. The total orunicompartmental knee replacement procedures are invasive and result insignificant pain and rehabilitation time for the patient.

There remains a need for less traumatic and bone sparing devices thatcan accomplish load bearing and joint function through a range of jointmotions. While existing devices, systems, and methods have attempted toaddress these issues, they have not been satisfactory in all respects.Accordingly, there is a need for the improved devices and methodsdescribed herein in accordance with the disclosure.

SUMMARY

This disclosure is directed to prosthetic joint replacement devicesdesigned to replace damaged soft tissue in bone joints, such as, forexample, a knee joint, a shoulder joint, or other joint. In someaspects, the prosthetic devices disclosed herein may be used to replacetissue such as a meniscus or cartilage that may be found betweenadjacent anatomical (bone and/or cartilage) structures in a joint.

In an example aspect, the present disclosure is directed to a two-partjoint replacement device for replacing a damaged soft joint tissue. Thedevice may include a free floating soft joint tissue replacementcomponent comprising a first tissue-interface surface shaped to engage afirst anatomical (bone and/or cartilage) structure of a joint havingdamaged soft tissue. The device may also include a free floating rigidbase component comprising a second tissue-interface surface shaped toengage a second anatomical (bone and/or cartilage) structure of thejoint. The free floating soft joint tissue replacement component may beshaped to slidably interface with the rigid base component. In anotheraspect, one or both of the free floating soft joint tissue replacementcomponent and the rigid base may include external passages, includingloops, for the passage of suture like materials to loosely connect thedevices to surrounding tissue while still allowing free floatingmovement in the joint space.

In another example aspect, the present disclosure is directed to amethod for inserting a two-part joint replacement device inside a jointbetween a first anatomical structure and an adjacent second anatomicalstructure. The method may include introducing a free floating soft jointtissue replacement component and a rigid base component between thefirst anatomical structure and the second anatomical structure of thejoint so that the free floating soft joint tissue replacement componentis disposed to slidingly engage inside the rigid base component. Theupper surface of the free floating soft joint tissue replacementcomponent may be positioned to engage the first anatomical structure. Abottom portion of the rigid base component may be positioned to engagethe second anatomical structure such that the two-part joint replacementdevice floats between the first and second anatomical structures.

In another example aspect, the present disclosure is directed to atwo-part floating soft joint tissue replacement prosthetic device forreplacing damaged soft tissue, such as a meniscus or cartilage, of ajoint. The device may include a free floating first soft joint tissuereplacement component comprising a first surface for engagement withfirst anatomical structure having damaged soft joint tissue, the firstsoft joint tissue replacement component being formed of a firstbiocompatible material. The device may also include a rigid basecomponent as a second component fixed with the first soft joint tissuereplacement component and comprising a bottom portion arranged toprovide free floating engagement with a second anatomical structure. Therigid base component may be formed of a second biocompatible materialmore rigid than the first biocompatible material and disposed for directengagement with anatomical tissue. In another aspect, the free floatingsoft joint tissue replacement device may include external passages,including loops, for the passage of suture like materials to looselyconnect the device to surrounding tissue while still allowing freefloating movement in the joint space.

BRIEF DESCRIPTION OF DRAWINGS

Other features and advantages of the disclosure will become apparent inthe following detailed description of embodiments of the disclosure withreference to the accompanying of drawings.

FIG. 1 is a diagrammatic view of a prosthetic meniscus device implantedin a left knee joint between femur F and tibia T, according to anexemplary implementation.

FIG. 2 is a diagrammatic perspective view of a prosthetic meniscusdevice, according to an exemplary implementation.

FIG. 3 is a diagrammatic perspective view of a rigid base component of aprosthetic meniscus device according to an exemplary implementation.

FIG. 4 is a diagrammatic perspective side view of a prosthetic meniscusdevice, according to an exemplary implementation.

FIG. 5 is a diagrammatic perspective front view of a free floatingmeniscus component of a prosthetic meniscus device, according to anexemplary implementation.

FIG. 6 is a diagrammatic cross sectional view of the free floatingmeniscus component of FIG. 5, according to an exemplary implementation.

FIG. 7 is a diagrammatic cross sectional view of a free floatingmeniscus component in a rigid base component, according to an exemplaryimplementation.

FIGS. 8A and 8B are diagrammatic perspective top and side views of theprosthetic meniscus device, according to an exemplary implementation.

FIG. 9 is a diagrammatic perspective view of a free floating meniscuscomponent disposed on a tibia according to an exemplary implementation.

FIGS. 10A, 10B, 10C, and 10D are diagrammatic illustrations of animplanted free floating meniscus component with the knee articulatedthrough a series of angles.

FIGS. 11A, 11B, and 11C are diagrammatic cross-sectional side views of aprosthetic meniscus device, according to an exemplary implementation.

FIG. 12 is a diagrammatic perspective view of a free floating meniscuscomponent disposed on a tibia according to an exemplary implementation.

FIG. 13 is a diagrammatic top view of a free floating meniscus componentdisposed on a tibia according to an exemplary implementation.

FIG. 14 is a flowchart illustrating an exemplary method of implanting aprosthetic meniscus device in accordance with an exemplaryimplementation.

DETAILED DESCRIPTION

For the purposes of promoting an understanding of the principles of thedisclosure, reference will now be made to the embodiments illustrated inthe drawings, and specific language will be used to describe theillustrated embodiments. It is nevertheless understood that nolimitation of the scope of the disclosure is intended. Any and allalterations or modifications to the described devices, instruments,and/or methods, as well as any further application of the principles ofthe disclosure that would be apparent to one skilled in the art areencompassed by the disclosure even if not explicitly discussed herein.Further, it is fully contemplated that the features, components, and/orsteps described with respect to one embodiment may be combined with thefeatures, components, and/or steps described with respect to otherembodiments of the disclosure.

FIG. 1 is a diagrammatic view of a two-part prosthetic meniscus device100 (also referred to as a joint replacement device) implanted in ajoint. The prosthetic meniscus device 100 may be used to replace tissuesuch as a meniscus or cartilage that may be found between adjacentanatomical (bone and/or tissue) structures in a joint. As used herein,bone structure on adjacent sides of a joint is typically not consideredto be soft-tissue. In the example shown, the joint is a left knee jointand the prosthetic meniscus device 100 is disposed between femur F andtibia T. In this example, the prosthetic meniscus device 100 isimplanted into the knee such that the prosthetic meniscus device floatsinside the knee joint. As used herein, the term “float” means that thedevice is not anchored in the joint using a mechanical device structure,such as a screw, a fin, a pointed protrusion, or other structure thatwould penetrate the bone or soft tissue like the joint capsule to securethe device in place. Because the prosthetic meniscus device 100 floatsinside the knee joint, the implant may not cause, or may at leastminimize, permanent damage to the patient's undamaged tibia or otherbone and/or soft tissue structure(s) engaged by the prosthetic meniscusdevice 100 in some embodiments. In some instances, the prostheticmeniscus device 100 is implanted to alleviate the patient's kneeproblems while avoiding permanent destruction of the patient's anatomy,which may occur if traditional joint repair techniques are used, such ascutting or reaming a large opening in the tibia or anchoring theprosthetic meniscus device 100 to the soft tissue. Because thesurrounding bone structure may remain largely or completely intact, insome instances, the prosthetic meniscus device 100 may be subsequentlyremoved and replaced with another prosthetic device or treatment withoutadversely affecting the subsequent treatment. While the prostheticmeniscus device 100 will be described herein primarily with reference toa knee joint meniscus device that may be disposed between a femur andtibia, other implementations of the prosthetic meniscus device aresuitably shaped and sized for implantation in a shoulder joint, an anklejoint, a hip joint, or other joint in the human body.

In some implementations, the prosthetic meniscus device 100 replacessome or all of the function of a natural meniscus and is configured tointeract with the opposing articulating cartilage surfaces to facilitatemovement of a joint with a damaged meniscus. In the example of a kneejoint, the prosthetic meniscus device 100 device may be disposed betweentibia and femur surfaces to facilitate movement of a knee joint having adamaged meniscus. In some implementations, the prosthetic meniscusdevice 100 is inserted between tibia and femur surfaces of a knee jointand prevents further deterioration of the medial meniscus andarticulating cartilage surfaces. In another embodiment, prostheticmeniscus device 100 serves as a temporary implant that is in place whilenatural meniscus is treated or regrown with a biologic. In that regard,the prosthetic meniscus device 100 can be disposed between and incontact with a lateral femoral bearing surface or medial femoral condylein the femur and the natural lateral tibial plateau in the tibia. In afurther embodiment, the prosthetic meniscus device 100 mimics thefunction of the natural meniscus and redistributes weight loadtransmitted across the knee joint, as well as protect the articulatingcartilages.

As illustrated in FIG. 1, prosthetic meniscus device 100 has beeninserted into the medial compartment of the native tibial plateau,according to an embodiment. Unlike conventional implants, prostheticmeniscus device 100 is not fixed to the bone or soft tissues of the kneejoint. Instead, prosthetic meniscus device 100 floats inside the medialcompartment between the femoral bearing surface and the native tibialplateau, and engages the femoral bearing surface and the native tibialplateau when the knee is in motion.

In an embodiment, the prosthetic meniscus device 100 includes a freefloating meniscus component 102 (also referred to as a soft joint tissuereplacement component) and a free floating rigid base component 104. Thefree floating meniscus component 102 has a circular or a semi-ellipticalbody. The free floating meniscus component 102 is a component ofprosthetic meniscus device 100 that redistributes weight loadtransmitted across the knee joint while protecting the cartilage of themedial femoral condyle and protect/delay from further damage to themeniscus implant by the native tibial plateau. In an embodiment, thefree floating meniscus component 102 is made of polycarbonate-urethane(PCU), a similar medical grade plastic, or a combination of one or moreplastics of same or different densities. Example plastics are describedin detail below. These plastics allow the free floating meniscuscomponent 102 to conform and fit the natural components of the kneejoint, and also adapt to the changes of the natural components of theknee joint with time and use.

In the illustrated embodiment, the free floating meniscus component 102is placed inside the rigid base component 104, such that the freefloating meniscus component 102 is surrounded by the rigid basecomponent 104 along its outer portion and bottom surface area. The rigidbase component 104 is placed inside the native tibial plateau of themedial compartment and prevents the free floating meniscus component 102from being expelled from the medial compartment, when, for example, theknee is in motion. Importantly, the rigid base component 104 is notfixed or attached to the native tibial plateau and is also free floatinginside the medial compartment. Like the free floating meniscus component102, rigid base component 104 can also be made of polycarbonate-urethane(PCU) or another similar medical grade plastic which may be of differentdensity/stiffness from the free floating meniscus component 102.Typically, the rigid base component 104 is made up of plastic that isdenser than the free floating meniscus component 102. In anotherembodiment, rigid base component 104 may be made of a bio-compatible,non-reactive metal, such stainless steel, cobalt chrome, or titanium, toname a few examples. In yet another embodiment, the rigid base component104 may be made of a bio-compatible ceramic material.

In other embodiments (not illustrated here), prosthetic meniscus device100 may also be utilized in other joints about the body. In addition, itmay be used in any of the other knee bearing surfaces and menisci, suchas the right knee medial meniscus, left knee lateral meniscus, and/orright knee lateral meniscus. In that regard, the size, shape, thickness,material properties, and/or other properties of the prosthetic meniscusdevice 100 may be configured for each particular application, and alsoto the size and shape of the knee, knee joints, shoulder, hip, ankle,compromised and non-compromised menisci, etc., of each patient.

FIG. 2 is a perspective view of the two-part prosthetic meniscus device100, according to an exemplary implementation. Referring to FIG. 2, thefree floating meniscus component 102 comprises a tissue-interfacingupper surface 202, a lower surface 204 (also shown in FIG. 7) and anouter portion 206. In some implementations, the outer portion 206 formsthe outer peripheral surface of the component 102 that extends betweenand connects the sides of the upper surface 202 and the lower surface204. In some implementations, the outer portion 206 is formed as amonolithic part of the component 102, and in some implementations, theouter portion 206 is formed of a wall structure or peripheral bumperformed or molded about the central portions forming the upper surface202 and the lower surface 204 of the free floating meniscus component102. In some implementations, such as when the free floating meniscuscomponent 102 is formed of two elements joined together, the peripheralwall structure or wall may have a circular or elliptical shape thatsurrounds and may be attached to the body of the free floating meniscuscomponent 102. The outer portion 206 may also comprise of adenser/stiffer material than the rest of the free floating meniscuscomponent 102.

In the illustrated embodiment, the upper surface 202 is shaped andarranged to face the medial femoral condyle and may press or engage thecartilage of the medial femoral condyle or the femoral surface. In someembodiments, the upper surface 202 may be custom molded to shape thecartilage of the medial femoral condyle of the host knee.

In some implementations, upper surface 202 may be shaped to form a basinor have a generally concave shape for the reception of adjacent bonestructure forming the joint. In some implementations, the upper surface202 may have one or more bone-relief recess areas, such as bone-reliefrecess area 208. Bone-relief recess area 208 is an indentation in theupper surface 202 of the free floating meniscus component 102. The bonerelief recess area 208 may be manufactured by any method includingmolding, machining, etching, or other method. The bone-relief recessarea 208 limits contact or engagement between the upper surface 202 andthe bone structure otherwise supported within the basin or concave shapeof the upper surface 202. For example, when the joint is a knee, thebone-relief recess area 208 may limit contact or engagement between theupper surface 202 and a portion of the medial femoral condyle that isopposite of the bone-relief recess area 208, while the upper surface 202still supports other portions of the medial femoral condyle. Thebone-relief recess area 208 may be shaped as an additional divot,depression, or etch formed in the upper surface 202.

Such limited contact between the upper surface 202 and a portion of theadjacent bone may be provided for medical reasons, for general comfort,or for other reasons. For example, when certain areas of the meniscus inthe bone structure at the treated joint have been damaged, furthercontact with prosthetic meniscus device 100 would exacerbate the damageor cause additional pain to the patient. In this case, when the freefloating meniscus component 102 with the bone-relief recess area 208 isinserted into the medial compartment such that the bone-relief recessarea 208 faces the damaged portion of the femoral bearing surface, thebone-relief recess area 208 may limit contact with the damaged surfaceand prevents further deterioration of the femoral bearing surface, whilethe remainder of upper surface 202 still provides supportive contactwith the non-damaged cartilage portions the bone structure.

In another example, limited contact between the prosthetic meniscusdevice 100 and the femoral bearing surface may be necessitated after apatient underwent a minimally invasive surgery to replace or repair aportion of the cartilage of the medial femoral condyle. One way toreplace or repair portions of the cartilage is to insert a biologic orstem cell paste into the damaged portions or the cartilage and allow thecartilage to regenerate and regrow. However, cartilage does notregenerate at a density required to bear weight in the knee joint unlesspressure is applied to the cartilage. Hence, in order for the cartilageto regenerate at a necessary density, a patient should apply pressure onthe knee and on the femoral bearing as the cartilage regenerates andregrows. In order for the patient to put pressure on the knee, yet forthe biologic or the stem cell paste to have limited or no contact withthe prosthetic meniscus device 100, the upper surface 202 includes thebone-relief recess area 208 that faces the portion of the medial femoralcondyle that has been injected with a biologic or stem cell paste. Thebone-relief recess area 208 may prevent or may limit contact between theprosthetic meniscus device 100 and the portion of the medial femoralcondyle that was injected with a biologic or the stem cell paste whilethe cartilage regenerates. Yet, at the same time, bone-relief recessarea 208 also allows a patient to apply pressure to the knee that causesthe cartilage to regenerate at a density that supports pressure on aknee joint.

In some implementations, rigid base component 104 comprises an outerportion 214 and a bottom portion 216. Generally, the outer portion 214is a rigid support structure or wall that forms an outer periphery ofthe base component 104 and has a circular or an elliptical shape thatimitates or substantially matches the shape of the outer portion 206 ofthe free floating meniscus component 102. The bottom portion 216 is alsoof a circular or elliptical shape and attaches to the lower end of theouter portion 214 on all sides. In some implementations, this outerportion 214 and the bottom portion 216 together form a basin or cup inwhich the free floating meniscus component 102 may be disposed. In someimplementations, the surface areas of an inner surface and an outersurface of the outer portion 214 may be smooth surfaces.

In some implementations, bottom portion 216 may be molded to conform tothe shape of the lower surface 204 and/or the shape of the naturalmedial tibial plateau of the host knee. The bottom portion 216 mayinclude a lower surface or tissue-interfacing surface that interfaceswith the bone/cartilage tissues of the joint.

In the illustrated embodiment, the free floating meniscus component 102is disposed inside the rigid base component 104, such that the lowersurface 204 of the free floating meniscus component 102 faces the uppersurface of the bottom portion 216 of the rigid base component 104. Here,the lower surface 204 and the upper surface of the bottom portion 216directly interface. In an embodiment, lower surface 204 may be a smoothsurface that is adjacent to the smooth surface of the bottom portion216. In another embodiment, lower surface 204 may be a molded surface,in which case, the upper surface of the bottom portion 216 is molded tothe shape of lower surface 204 or vice versa. In yet another embodiment,lower surface 204 may be a concave surface and the upper surface of thebottom portion 216 may also be a concave surface. In additionalembodiments, they are each planar.

Referring to FIG. 2, when the free floating meniscus component 102 islocated inside the rigid base component 104, the outer portion 214 andthe bottom portion 216 surround the free floating meniscus component102. Accordingly, the bottom portion 216 provides a load bearing surfacethrough which loads on the joint may be passed, and the outer portion214 may be a boundary or limit upon the distance that the free floatingmeniscus component 102 may translate as it free floats within the rigidbase component 104. In the illustrated embodiment, the upper surface 202and upper portions of the outer portion 206 protrude above the outerportion 214 of rigid base component 104. This may provide axialseparation of the upper bone structure from the lower component of thedevice 100, which in this example is the rigid base component 104.

FIG. 2 shows that the prosthetic meniscus device 100 has a height orthickness 210, a longitudinal width 212 that may be measured along thelargest transverse cross-sectional length, and a transverse width 220that is the smallest cross-sectional length taken perpendicular to thelongitudinal width 212. The thickness or height 210 may be measured asthe combined height of the free floating meniscus component 102 and therigid base component 104. Also, the thickness or height 210 may varydepending upon the measured location. For example, the nonplanar uppersurface 202 of the free floating meniscus component 102 and thenonplanar lower surface 308 of the rigid base component 104 may impactthe thickness or height 210 at any particular location of the prostheticmeniscus device 100. Generally, in addition to the surface variationsand shapes of the upper surface 202, the thickness or height 210 may beselected to fit within the available space between the femoral bearingsurface and the natural tibial plateau of a host knee. In someimplementations, the thickness or height 210 may be between 0.5 mm and15 mm. In some implementations, the maximum height 210 measured alongthe outer edges of the may be about 10 mm and the minimum thickness orheight 210, which may be measured in the central portion of theprosthetic meniscus device 100 may be about 2 mm. Other thicknesses orheights, both smaller and larger are contemplated.

In some implementations, the longitudinal width 212 of prostheticmeniscus device 100 may be the width of rigid base component 104 sincethe width of the rigid base component will generally be larger than thewidth of the free floating meniscus component 102. Generally, thelongitudinal width 212 may be dictated by the available space betweenthe medial femoral bearing surface and the natural medial tibial plateauof a host knee. The longitudinal width 212 may be between 25 mm and 70mm, although larger and smaller widths are contemplated.

In some implementations, the transverse width 220 of the prostheticmeniscus device 100 may be the shortest measurable width of the rigidbase component 104 that is perpendicular to the longitudinal width 212.Generally, the transverse width 220, like the longitudinal width 212,may be dictated by the available space between the femoral surface andthe natural medial tibial plateau of a host knee. The transverse widthmay be between 20 mm and 50 mm in some implementations, although largerand smaller transverse widths are contemplated.

In some implementations, the inner dimensions of the outer portion 206may be larger than the outer dimensions of the free floating meniscuscomponent 102 so as to provide a gap or space 218 therebetween. Thespace 218 provides clearance between the outer portion 206 and the freefloating meniscus component 102 so that the free floating meniscuscomponent 102 may laterally translate or rotate while disposed in theouter portion 206. The inner surface of the outer portion 206 may act asa boundary to limit the amount of translation and to maintain the freefloating meniscus component 102 within the outer portion 206. The sizeof the gap or space 218 may vary depending on the application and thejoint to be replaced. In some implementations, the space 218 may bebetween 0.5 mm and 3 mm, but the implementation is not limited to thisembodiment. In a different embodiment, the space may so small such thatthe outer portion 214 and inner surface of the outer portion 206 may besubstantially abutting around the complete outer portion to limittranslation in any direction.

In some implementations, the wall formed by the outer portion 206 of therigid base component 104 prevents free floating meniscus component 102from being expelled from the joint. At the same time, the rigid basecomponent 104 allows free floating meniscus component 102 to floatfreely therein, and the prosthetic meniscus device 100 may mimicfunctionality of the natural meniscus. Further, because the rigid basecomponent 104 also floats within the joint, the natural meniscus and thesupporting femur and tibia may remain intact. That is, since tissuepenetrating anchors are not employed in some embodiments of theprosthetic meniscus device 100, additional trauma to the joint may bereduced or minimized when compared to conventional devices.

FIG. 3 is a perspective view of the rigid base component 104 of theprosthetic meniscus device 100, according to an example implementation.The rigid base component 104 may be formed of a rigid, supportivematerial such as a metal, a plastic, and/or a ceramic material. Asillustrated in FIG. 3, the outer portion 214 and the bottom portion 216together form a basin or cup defining a containment cavity 217 that isshaped to receive the free floating meniscus component 102 (FIG. 2). Theouter portion 214 forms the peripheral wall of rigid base component 104and comprises an inner surface 302 and an outer surface 304. The innersurface 302 of the rigid base component 104 faces the outer portion 206of the free floating meniscus component 102 when the free floatingmeniscus component 102 is disposed therein. In some embodiments, innersurface 302 may be a smooth surface and may be arranged to provide alimit or restraint on the distance that the free floating meniscuscomponent 102 may translate in the containment cavity 217.

In some implementations, the outer surface 304 of rigid base component104 may be shaped to be positioned inside the boundaries of the joint,such as, for example, within a medial compartment of the knee. This maypermit the outer surface 304 to be surrounded by the meniscus in thenative tibial plateau. In some implementations, the rigid base component104 may be positioned within boundaries of the joint, such as the nativetibial plateau such that the bottom portion 216 is adjacent and conformsto the shape of the meniscus inside the native tibial plateau.

In some implementations, the bottom portion 216 of rigid base component104 comprises the upper surface 306 and the lower surface 308. As shownin FIG. 3, the upper surface 306 of the bottom portion 216 may be moldedto have a non-planar, uneven surface that may be arranged to match thelower surface 204 of the free floating meniscus component 102. In someimplementations, the lower surface 308 of the bottom portion 216 may bemolded to fit the underlying bone structure against which it abuts. Forexample, when the rigid base component 104 is a knee implant, the lowersurface 308 may be molded to fit a natural tibial plateau and/or themeniscus surrounding the native tibial plateau, such that the nativetibial plateau and the meniscus provide support for keeping the rigidbase component 104 in place. Since the lower surface 308 abuts directlyagainst and interfaces with bone and/or cartilage structures, such aform-fit surface may help maintain the free floating rigid basecomponent 104 in place, even though free floating displacement may beexpected. That is, variations in the height or thickness of the surfacesmay be selected to match the anatomical features of the patient in someembodiments in the form of a natural meniscus.

In some implementations, the thickness or height 310 of the outerportion 214 or wall may vary between a maximum height or thickness inthe range of 10 mm to 20 mm and may vary between a minimum height of 2mm to 10 mm depending upon the location and/or the size of the patient.Height variations may be due to the preformed shape of the bottomportion 216 to coincide with the lower surface 204 of the free floatingmeniscus component 102 and/or with the shaped of the adjacentbone/cartilage structure, such as the native tibial plateau. In someimplementations, the height 310 of outer portion 214 varies from amaximum height of 20 mm to a minimum height of 10 mm. In otherimplementations, the height 310 varies from a height of 15 mm to aheight of 5 mm. Other amounts are also contemplated. In someimplementations, the wall thickness 312 of the outer portion 214measured between inner surface 302 and the outer surface 304 may bebetween 0.1 mm and 3 mm. In one particular embodiment, the wallthickness 312 may be about 1 mm.

FIG. 4 is a perspective side view of the prosthetic meniscus device 100with a free floating meniscus component 102 disposed inside rigid basecomponent 104, according to one embodiment. As illustrated in FIG. 4,the lower surface 308 of the bottom portion 216 in the rigid basecomponent 104 is molded to match the shape of a bone or tissueinterface, such as the shape of the native tibial plateau. As alsoillustrated in FIG. 4, the height 310 of the outer portion 214 variesbecause a lower end 215 forming a peripheral bottom edge of the outerportion 214 conforms to the nonplanar variations in the slope of lowersurface 308, while the upper end 223 forming the upper edge of the outerportion 214 remains at approximately the same height with respect toupper edge 219 the free floating meniscus component 102.

In some implementations, the variation of the surface profile of thebottom surface may be measured as a surface variation or height 311between 0.1 mm and 10 mm. This height may be measured as an axialdistance along an axis 221 defined by the surface forming the outerportion 214 of the rigid base component 104. The height variations maybe due to the shape of the bottom portion 216 that coincides with thelower surface 204 of the free floating meniscus component 102 and/orwith the adjacent tissue structure, such as the native tibial plateau ofthe host knee.

FIGS. 5 and 6 show a free floating meniscus component 102 of theprosthetic meniscus device 100. Some features may be similar to a priordesign set forth in U.S. Pat. No. 8,361,147, which is herebyincorporated by reference in its entirety. The body of free floatingmeniscus component 102 comprises an outer body portion 108 (referred toas the outer portion 206 in FIG. 2) and a central body portion 110.Generally, the outer body portion 108 has an increased thickness andheight relative to the central body portion 110. In some instances theouter body portion 108 has a thickness between 5 mm and 15 mm. In someinstances, the central body portion 110 has a thickness between 0.5 mmand 5 mm. In one particular embodiment, the outer body portion 108 has amaximum thickness of approximately 10 mm and the central body portion110 has a maximum thickness of approximately 2 mm. The height orthickness of the outer body portion 108 varies around the perimeter ofthe prosthetic device in some instances. In that regard, the variationsin the height or thickness of the outer body portion 108 are selected tomatch the anatomical features of the patient in some embodiments.Similarly, the height or thickness of the central body portion 110varies across the prosthetic device in some embodiments. Again, thevariations in the height or thickness of the central body portion 110are selected to match the anatomical features of the patient in someembodiments. In some embodiments, the free floating meniscus component102 is inserted in an insertion configuration and then loaded,stretched, moved, and/or otherwise transferred to an implantationconfiguration. In some implementations, the insertion configuration hasa smaller profile or shape then the implantation configuration. In otherimplementations, the insertion configuration is simply different thanthe implantation configuration in order to accommodate insertion betweenthe bones of the joint. In some embodiments the transformation betweenthe insertion configuration and the implantation configuration isfacilitated through the application of a loading force of the freefloating meniscus component 102. In such embodiments, the variations inheight or thickness of the outer and central body portions 108, 110 areselected to accommodate the deformation or transformation between theinsertion configuration and the implantation configuration.

To this end, the outer body portion 108 of the free floating meniscuscomponent 102 includes a first portion 112 and a second portion orbridge 114. In some embodiments, the first portion 112 substantiallymatches the shape of a natural meniscus. In some embodiments, the outerbody portion 108 has a circular or semi-ellipsoidal shape. Accordingly,the first portion 112 extends around a majority of the outer bodyportion 108. The bridge 114 connects the two ends of the first portion112. Thus, where the prosthetic device is configured for use as a medialmeniscus device, the bridge 114 extends along the lateral side of thedevice. Where the free floating meniscus component 102 is configured foruse as a lateral meniscus device, the bridge 114 extends along themedial side of the device. Accordingly, the outer body portion108—comprised of the first portion 112 and the bridge 114 and having anincreased thickness relative to the central body portion 110—completelysurrounds the central body portion 110 and serves to limit movement ofthe prosthetic device after implantation.

The height or thickness of the bridge 114 is based on the size of thefemur notch and the distance to the cruciate ligaments in someembodiments. In some embodiments, the bridge 114 has a maximum height orthickness that is between ¼ and ¾ the maximum height or thickness of thefirst portion 112 of the outer body portion 108. In some embodiments,the size and shape of the bridge 114 is selected to achieve an optimalpressure distribution on the native tibial plateau in order to mimic thepressure distribution of a healthy natural meniscus. The bridge 114 and,more generally, the outer body portion 108 are geometricallycharacterized by anterior, posterior, lateral-anterior, mid-lateral andlateral-posterior angles and heights as well as sagittal and coronalradii of curvature. Further, the outer body portion 108 and the centralbody portion 110 are shaped and sized such that the free floatingmeniscus component 102 is self-centering within rigid base component104. That is, the shape and size of the prosthetic meniscus deviceitself encourages the prosthetic device to position or align itself witha desired orientation within the knee joint based on the position of thefemoral surface. Accordingly, as the free floating meniscus component102 moves through a range of positions within the knee joint, itnaturally returns to the desired orientation due to the shape and sizeof the outer and central body portion 108, 110. In some embodiments, theouter body portion and, more specifically, the bridge 114 alone ortogether with rigid base component 104 acts as a physical barrierlimiting the movement of the prosthetic device caused by joint reactionforces. The shape of the related femoral or tibial bearing componentinteracting with the self-centering or self-aligning mechanism combinedwith the free floating meniscus component's 102 ability to move withinthe knee joint results in improved location of the prosthetic meniscusdevice 100 during typical gait cycles (e.g., flexion-extension angles of0° to 20° or “heel-strike” to “toe-off”). The result is that the freefloating meniscus component 102 exhibits a load pressure distributionsimilar to that of a natural meniscus.

The central body portion 110 defines an upper surface 116 and a lowersurface 118 (referred to as upper surface 202 and lower surface 204 inFIG. 2.). The upper surface 116 may interface with the tissue structureof the joint and may form a part of a bearing surface. In particular,the upper surface 116 is configured to movingly engage with a medialfemoral condyle of the femur. In that regard, free floating meniscuscomponent 102 can translate and rotate with respect to the femur and/ortibia within a range. In some instances, translation is possible in boththe anterior-posterior and medial-lateral directions. In someembodiments, the upper surface 116 includes both a vertical andhorizontal surface. To that end, in some embodiments the upper surface116 comprises a concave surface that defines the vertical and horizontalsurfaces. The thickness of the central body portion 110 between theupper surface 116 and the lower surface 118 supports stress distributioncapability of the component, while the increased height of the uppersurface 116 as it extends outwardly towards the outer body portion 108defines the horizontal surface of the component. Similarly, in someembodiments the lower surface 118 includes both vertical and horizontalcomponents. In particular, in some embodiments the lower surface 118comprises a convex surface or a concave surface that is molded to theshape of the inside portion of rigid base component 104.

The thickness of the central body portion 110 between the upper surface116 and the lower surface 118 determines the load distribution capacityof the component, while the tapered height of the lower surface 116 asit extends outwardly towards the outer body portion 108 defines thehorizontal component. In some embodiments, the upper surface 116 and/orthe lower surface 118 are shaped such that the component is biasedtowards a neutral position in the knee. For example, the arcuateprofiles of the upper surface 116 and/or the lower surface 118 areshaped such that the interaction between the surfaces and the femoralsurface encourages the implant to a particular orientation relative tothe surfaces.

Referring to FIG. 6, shown therein is a diagrammatic cross-sectionalview of free floating meniscus component 102 taken along an anterior toposterior section line between anterior end 113 and posterior end 115.The central body portion 110 is reinforced by pre-tensioned fibers 124wound around the core to inhibit outward deformation while allowinginward flexibility. As shown, the anterior end 113 of the outer bodyportion 108 has an anterior height or thickness 160. In that regard, theanterior height or thickness 160 of the anterior end 113 is betweenabout 4 mm and immediately adjacent bridge 114 could be as great asabout 15 mm and, in some instances, is between about 5.7 mm and about9.3 mm. In the illustrated embodiment, the anterior height or thickness160 of the anterior end 113 is approximately 7.8 mm. In a smallerembodiment, the anterior height or thickness 160 is approximately 5.7mm. In a larger embodiment, the anterior height or thickness 160 isapproximately 9.3 mm. The posterior height or thickness 162 of theposterior end is between about 4 mm and immediately adjacent the bridge114 could be as great as about 20 mm and, in some instances, is betweenabout 7.7 mm and about 12.7 mm. In the embodiment, the posterior heightor thickness 162 of the posterior end 115 is approximately 9.0 mm. In asmaller embodiment, the posterior height or thickness 162 isapproximately 7.7 mm. In a larger embodiment, the posterior height orthickness 162 is approximately 12.7 mm.

The anterior portion of the upper surface of the anterior end 113 has ananterior radius of curvature 164. In that regard, the anterior radius ofcurvature 164 is between about 10 mm and about 100 mm and, in someinstances, is between about 23.0 mm and about 33.1 mm. In theembodiment, the radius of curvature 164 is approximately 72 mm. Inanother embodiment, the radius of curvature 164 is approximately 28 mm.In a smaller embodiment, the radius of curvature 164 is approximately 23mm. In a larger embodiment, the radius of curvature 164 is approximately33.1 mm. The posterior portion of the upper surface of the posterior end115 has a posterior radius of curvature 166. In that regard, theposterior radius of curvature 166 is between about 5 mm and about 70 mmand, in some instances, is between about 15.2 mm and about 24.2 mm. Inthe illustrated embodiment, the radius of curvature 166 is approximately30 mm. In a smaller embodiment, the radius of curvature 166 isapproximately 15.2 mm. In a larger embodiment, the radius of curvature166 is approximately 24.2 mm.

Further, the anterior portion 113 of the upper surface generally extendsat an anterior angle 168 with respect to an axis 170 extendingsubstantially perpendicular to a plane generally defined by the freefloating meniscus component 102, as shown. The anterior angle 168 isbetween about 45 degrees and about 75 degrees and, in some instances, isbetween about 62 degrees and about 68 degrees. In the illustratedembodiment, the angle 168 is approximately 65 degrees. In a smallerembodiment, the angle 168 is approximately 62 degrees. In a largerembodiment, the angle is approximately 68 degrees. The posterior end 115of the upper surface generally extends at an posterior angle 172 withrespect to an axis 174 extending substantially perpendicular to a planegenerally defined by the prosthetic meniscus device 100, as shown. Theposterior angle 172 is between about 35 degrees and about 70 degreesand, in some instances, is between about 55 degrees and about 61degrees. In the embodiment, the angle 172 is approximately 58 degrees.In a smaller embodiment, the angle 172 is approximately 50 degrees. In alarger embodiment, the angle 172 is approximately 65 degrees.

The central body portion 110 has a height or thickness 176 between thearticulating upper surface 116 and the articulating lower surface 118.In some embodiments, the height or thickness 176 is the minimalthickness of the central body portion 110 and, in more specificembodiments, the minimal thickness of the entire free floating meniscuscomponent 102. To that end, the height or thickness 176 is between about1 mm and about 3 mm and, in some instances, is between about 1.2 mm andabout 2.1 mm. In the embodiment, the height or thickness 176 isapproximately 1.5 mm. In a smaller embodiment, the height or thickness176 is approximately 1.2 mm. In a larger embodiment, the height orthickness 176 is approximately 2.1 mm.

FIG. 7 is a cross-sectional view of the prosthetic meniscus device 100with the free floating meniscus component 102 disposed inside thecontainment cavity 217 of the rigid base component 104. As illustratedin FIG. 7, the bottom portion 216 of rigid base component 104 isadjacent to the outer body portion 108 of the free floating meniscuscomponent 102. As also illustrated in FIG. 7, the bottom portion 216 ofthe rigid base component 104 may have a generally concave shape. In someimplementations, the bottom portion 216 is shaped to form fit or receivethe surface of the outer body portion 108. As also illustrated in FIG.7, the bottom portion 216 may have an edge portion 702 that extendsalong the outer edge of the bottom portion 216.

As discussed above, the free floating meniscus component 102 and therigid base component 104 may be sized so that the outer portion 206 ofthe free floating meniscus component 102 and the outer portion 214 ofthe rigid base component 104 may be separated by the gap or space 218.This gap or space 218 may permit the free floating meniscus component102 to rotate or translate within the rigid base component 104. In oneembodiment, the outer portion 206 and the outer portion 214 may haveouter surfaces generally parallel to each other along axis 706 extendingsubstantially perpendicular to a plane generally defined through theprosthetic meniscus device 100, as shown. In another embodiment, outerportion 206 generally extends at angle 708 with respect to axis 706 awayfrom the outer portion 214 and toward the center of the free floatingmeniscus component 102. Depending upon the implementation, the angle 708is between 0 degrees and 45 degrees. In some implementations, the angle708 is between 5 degrees and 20 degrees.

FIG. 7 shows an exemplary implementation of the free floating meniscuscomponent 102. In this implementation, the free floating meniscuscomponent 102 comprises a bearing portion 720 cooperatively joined witha peripheral support portion 722. In this implementation, the peripheralsupport portion 722 forms outer body portion 108 described herein. Here,the bearing portion 720 comprises the upper surface 202 and the lowersurface 204, and is configured to interface with tissue at the joint andprovide bearing support for weight at the joint.

In this implementation, the bearing portion 720 comprises outer edges724 that abut against the peripheral support portion 722. These outeredges 724 comprise tension apertures 726. In this implementation, thetension apertures 726 extend fully around the periphery at the outeredge 724 of the bearing portion 720. In some implementations, thetension apertures 726 may receive fibers (not shown in FIG. 7), similarto or the same as the pre-tensioned fibers 124 in FIG. 6. Such fibersmay wind around the bearing portion 720 in the tension apertures 726 toinhibit outward deformation while allowing inward flexibility. In otherimplementations, instead of fibers, alternative reinforcement materialmay be introduced or embedded in the tension apertures 726. Someimplementations are devoid of tension apertures 726.

The peripheral support portion 722 may be structurally embedded in aportion of the bearing portion 720 so as to be partially enveloped inthe bearing portion 720 as shown in FIG. 7. In some implementations, theperipheral support portion 722 may be formed of a more rigid materialthan the bearing portion 720, and may provide rigidity and strength tothe free floating meniscus component 102. In the implementation shown,edges of the bearing portion 720 and develop an interface with the upperand lower surfaces of the peripheral support portion 722. However, otherarrangements may be used to securely maintain the peripheral supportportion 722 in place about the bearing portion 720. In someimplementations, the bearing portion 720 and the peripheral supportportion 722 are formed of the same material. In one exemplaryimplementation, the peripheral support portion 722 may have one or moreextending ridges, hooks, or notches that may extend into one or more ofthe tension apertures 726. In some implementations, the ridges, hooks,or notches may extend into other grooves or reception cavities formed inthe outer edge of the bearing portion 720. These types of arrangementsmay provide mechanical interference that prevents the bearing portion720 from displacing vertically relative to the peripheral supportportion 722.

In use, under a bearing load, the bearing portion 720 of the freefloating meniscus component 102 may be formed to match the profile ofthe more rigid bottom portion 216 of the rigid base component 104.Accordingly, although gaps are shown between the lower surface 204 ofthe free floating meniscus component and the upper surface 306 of therigid base component, under load, these gaps may be minimized orreduced. Furthermore, under load, the concave cavity of the freefloating meniscus component 102 may change shape slightly, such as theradius of curvature may be increased as a result of the applied loading.Additionally, the outer edges 724 of the bearing portion 720 may applyloading on the peripheral support portion 722, causing some deformationor expansion of the peripheral support portion 722. As discussed above,fibers or other materials may be used to limit, restrain, or control,the amount of deformation permitted under a load.

FIGS. 8A and 8B are top and side perspective views of the prostheticmeniscus device 100 with the free floating meniscus component 102disposed inside the rigid base component 104, according to an exemplaryimplementation. As illustrated in FIGS. 8A and 8B, the free floatingmeniscus component 102 may have a circular or semi-elliptical shape, andis disposed inside rigid base component 104 that may also have acircular or semi-elliptical shape that generally conforms to the shapeof rigid base component 104. As also illustrated in FIGS. 8A and 8B, gapor space 218 is maintained between components 102 and 104, but may varyin width 802 in order to allow the free floating meniscus component 102to float inside rigid base component 104. In some embodiments, the width802 of may fall within the range of between 0.05 mm and 3 mm. In someimplementations, width 802 may change as the free floating meniscuscomponent 102 floats inside the rigid base component 104 as the knee isin motion.

As discussed above, the prosthetic meniscus device 100 is a minimallyinvasive implant that floats inside the medial compartment of the kneejoint and prevents further damage to the meniscus and/or other tissueslike cartilage articulating surfaces. The prosthetic meniscus device 100may also protect a structural carrier, such as morsalized bone or acartilage matrix, which may include a biologic, that may be introducedin the medial femoral condyle to promote tissue regeneration andregrowth of the damaged cartilage. In some implementations, theprosthetic meniscus device 100 may be implanted into the native tibialplateau of the host knee such that the free floating meniscus component102 engages the femoral surface and redistributes weight loadtransmitted across the knee joint, while the rigid base component 104engages the natural tibial plateau and prevents the free floatingmeniscus component 102 from being unintentionally expelled from the kneejoint. As discussed above, the free floating meniscus component 102 maybe modified to have limited contact with one or more portions of thefemoral surface as dictated by the treatment. For example, when thedamaged area of the medial femoral condyle has been treated with abiologic or stem cell paste to allow cartilage to regenerate and regrow,the free floating meniscus component 102 may include one or morebone-relief recess areas, such as bone-relief recess area 208 thatlimits contact between the prosthetic meniscus device 100 and thetreated areas of the medial femoral condyle. Depending upon theimplementation, the bone relief recess areas may be custom formed tomatch individual patients or conditions.

In a further embodiment, the free floating meniscus component 102 withthe bone-relief recess area 208 may be swapped out or exchanged foranother free floating meniscus component 102 with a differentbone-relief recess area 208 or for the free floating meniscus component102 with a smooth upper surface 202. For example, once the medialfemoral condyle has healed and the cartilage had regrown, the freefloating meniscus component 102 with the bone-relief recess area 208 maybe exchanged in a revision surgery for the free floating meniscuscomponent 102 with the smooth upper surface 202.

FIG. 9 shows an example illustration of the prosthetic meniscus device100 disposed upon the tibia T of a knee joint with an injured meniscus10. The meniscus includes an outer rim 15 that is anchored to the bonealong the posterior rim 20 and the anterior rim 22. The meniscus mayform a meniscus pocket defined by a sidewall 21 of the meniscus, and inwhich the prosthetic meniscus device 100 may be disposed. The prostheticmeniscus device 100 engages not only the tibia T, but also the Femur(not shown in FIG. 9.)

In some implementations, the prosthetic meniscus device 100 may beimplanted in a two-step process. In the first step, only a temporaryfree floating meniscus component 102 may be implanted into the kneejoint. The implanted free floating meniscus component 102 may comprise asmooth upper surface 202 or have one or more bone-relief recess areas,such as bone-relief recess area 208 formed, such as by etching, on theupper surface 202, depending on the treatment. For example, a patientmay be required to gradually apply pressure on the cartilage in the kneefollowing a minimally invasive surgery in order for the cartilage toregrow and have necessary density, as described above. The free floatingmeniscus component 102 having a smooth upper surface 202 with thebone-relief recess area 208 opposite the areas in the medial femoralcondyle where the cartilage is being regrown, allows the patient toapply pressure across the entire knee joint, including the areas wherethe cartilage is being regrown, yet limits the physical contact withthese areas and the free floating meniscus component 102.

In some implementations, the second step of the two-step surgicalprocess may be performed days, weeks, or months after the first step ofthe surgical process. This may allow some healing to occur prior to thesecond step. For example, the second step of the two-step surgicalprocess may be performed after cartilage has begun growing on the medialfemoral condyle or other bone structure. In the second step, the freefloating meniscus component 102 may be replaced with a full prostheticmeniscus device 100, including the free floating meniscus component 102and the rigid base component 104. The free floating meniscus component102 can be the same or different free floating meniscus component 102 asin the first step. In some implementations, the free floating meniscuscomponent 102 may have a smooth upper surface 202. As indicated herein,the second step generally occurs after the cartridge has healed or hasbeen regrown and the prosthetic meniscus device 100 is implanted intothe knee joint for the long term use by the patient.

FIGS. 10A, 10B, 10C, and 10D show a series of angular positions of thefemur in relation to the tibia and the correspondent movement of theprosthetic meniscus device 100 in the knee joint. In FIG. 10A, femoralaxis FA is substantially aligned with the tibial axis TA. The prostheticmeniscus device 100 is disposed between the tibia T and the femur F. Inthis initial position, with the axes FA and TA substantially aligned,the outer surface of the outer portion 214 of the rigid base component104 may be generally aligned with a posterior wall of the joint,referenced by the reference line 550. In this position, the posteriorgap or space 218 between the outer portion 214 of the rigid basecomponent and the outer body portion 108 of the free floating meniscuscomponent 102 is indicated by the reference number D1.

FIG. 10B illustrates the movement of the prosthetic meniscus device 100as the femur F is moved to the position of the angle α′ between axis FAand axis TA. A comparison of FIGS. 10B and 10A shows that the rigid basecomponent 104 is maintained substantially in place, while the freefloating meniscus component 102 has displaced within the containmentcavity 217 of the rigid base component 104. In this instance, the freefloating meniscus component 102 may have moved in the posteriordirection as far as it is able. That is, it may have displaced to thepoint that the outer body portion 108 of the free floating meniscuscomponent has engaged the outer portion 214 of the rigid base component104. Because of this lateral translation, the gap or space 218 is shownnow on the interior side of the joint. In this instance, the gap orspace 218 is indicated by the reference number D2, which will equal D1in FIG. 10A so long as rotation is limited. Accordingly, D2 in FIG. 10Bis equal to or substantially equal to D1 in FIG. 10A.

FIG. 10C illustrates the continued rotation of the femur with respect tothe tibia results in angle α″ which is greater than angle α′. Acomparison of FIGS. 10B and 10C shows that the rigid base component 104,which is also free floating, begins displacing in the posteriordirection a distance D3.

FIG. 10D illustrates that continued rotation of the femur with respectto the tibia to angle α′″, which is substantially 90 degrees, results infurther translation to a distance D3′ which is greater than D3.

While the foregoing are not limiting, the total translation distance canrange from 3-20 mm in the anterior to posterior plane, with oneembodiment having D1 and D2 of 3 mm, D3 of 7 mm and D3′ of 14 mm.Similarly, the rotational angle can range, without limitation, from 3 to30 degrees of total angular rotation. An advantage of the free floatingsystem comes because the prosthetic device may also rotate in the jointas the angle of the femur and tibia changes.

FIGS. 11A, 11B, and 11C disclose cross-sectional side views of aprosthetic meniscus device 850. Similar to the device 100 describedabove, the prosthetic meniscus device 850 may include a floatingmeniscus component 852 and a rigid base component 854. In thisimplementation however, the free floating meniscus component 852 and therigid base component 854 have a particular shape that may providebiofeedback such as tactile feedback to a patient when the jointarticulation begins to exceed a desired amount. In the implementationshown, the particular shape provides an abrupt backstop to prevent thefree floating meniscus component 852 from translating beyond a desiredposition in the posterior direction. The particular shape also providesan increasing or gradual resistance to anterior displacement of the freefloating meniscus component 852 relative to the rigid base component854.

The prosthetic meniscus device 850 may be shaped generally in the samemanner described herein with reference to the prosthetic meniscus device100, but with some modifications described with reference to FIGS.11A-11C

FIG. 11A shows a cross-sectional view of the prosthetic meniscus device850 with the free floating meniscus component 852 disposed in thecup-shaped rigid base component 854. As can be seen, the peripheraledges of the free floating meniscus component 852 and the rigid basecomponent 854 are modified from other devices described herein. The freefloating meniscus component 852 includes a posterior peripheral portion856 and an anterior peripheral portion 858. It also includes a slidingbone or tissue interface surface 860 and a sliding interface 862.Likewise, the rigid base component 854 includes a posterior peripheralportion 866, and anterior peripheral portion 868, a tissue interfacesurface 870, and a sliding interface 872. As shown in FIG. 11A, theprosthetic meniscus device 850 has a height H1 when the free floatingmeniscus component 852 is disposed such that the sliding interface 862and the sliding interface 872 are engaged at their lowest portions. Theheight H1 may be measured from the tissue interface surface 870 to thetissue interface surface 860.

The posterior peripheral portion 856 of the free floating meniscuscomponent 852 includes a substantially vertical peripheral edge 871.Likewise the posterior peripheral portion 866 of the rigid basecomponent 854 includes a substantially vertical peripheral edge 873. Assuch, when the free floating meniscus component 852 slides and abutsagainst the posterior peripheral portion 866, the free floating meniscuscomponent may come to an abrupt stop. Also, when the free floatingmeniscus component 852 is disposed posteriorly in the rigid basecomponent 854, the prosthetic meniscus device 850 has the height H1.

The anterior peripheral portion 858 of the free floating meniscuscomponent 852 includes a curved or tapered edge 874. The curved edge 874extends from an upper portion of the free floating meniscus componentand tapers inwardly. The anterior peripheral portion 868 of the rigidbase component 854 also includes a curved or tapered edge 876. In someimplementations, such as the one shown in FIG. 11A, the curved ortapered edge is disposed on both the interior portion and the exteriorportion of the rigid base component 854. That is, the interior andexterior profiles of the rigid base component 854 substantially match.In other implementations, the curved or tapered edge 876 is disposedonly on the interior portion of the rigid base component 854. That is,the exterior profile of the rigid base component 854 may not match theinterior profile of the rigid base component 854. The purpose of thecurved or tapered edges of the anterior peripheral portions 858 and 868will become apparent with reference to FIGS. 11B and 11C.

FIG. 11B shows the prosthetic meniscus device 850 with the free floatingmeniscus component 852 translated toward the anterior peripheral portion868 of the rigid base component 854. In this exemplary embodiment, theprofile of the anterior peripheral portion 858 of the free floatingmeniscus component 852 and the profile of the anterior peripheralportion 868 of the rigid base component 854 substantially correspond toone another. In other embodiments, the profiles of the anteriorperipheral portions may not match. In some implementations, the locationof the free floating meniscus component 852 at the anterior portion ofthe rigid base component 854 may represent a preferred distal position.Thus, in some implementations, the rigid base component 854 is sized topermit the free floating meniscus component 852 to translate from thelocation shown in FIG. 11A to the location shown in FIG. 11B. In someimplementations, this may be determined to be a standard or typicalamount of translation as the knee articulates about the joint.

FIG. 11C shows the prosthetic meniscus device 850 with the free floatingmeniscus component 852 translated past the position shown in FIG. 11B.Likewise, the free floating meniscus component 852 may be translated toa location beyond that found during normal acceptable knee articulation.As can be seen, as the free floating meniscus component 852 begins totranslate along the sloped or angled edge 876 of the anterior peripheralportion 868 of the rigid base component, the leading anterior edge ofthe free floating meniscus component 852 rises, thereby changing theoverall height of the prosthetic meniscus device 850. FIG. 11C shows theoriginal height H1 and the increased height H2 which represents theoverall height of the prosthetic meniscus device 850 when the freefloating meniscus component 852 has moved beyond a typical or normallevel of displacement on the rigid base component 854.

As can be seen, posterior motion of the free floating meniscus component852 reaches a hard stop when the posterior peripheral portion 856 abutsagainst the posterior peripheral portion 866. This is because these twocomponents each have substantially vertical surfaces causing an abruptstop when they meet. In contrast, the anterior peripheral portion 858and the anterior peripheral portion 868 provide a gradual stop. Thesloped or angled leading surfaces cause a vertical displacement of thefree floating meniscus component 852 relative to the rigid basecomponent 854. In this implementation, the sloped or angled leadingsurface of the anterior peripheral portion 868 has a curvature. Thiscurvature provides a nonlinear increase in height from H1 to H2. Someimplementations use planar ramps that may provide a linear increase inheight. Other implementations use a series of planar ramps withdifferent angles.

In some implementations, this vertical displacement may be felt ornoticeable by the patient as tactile biofeedback in the knee. Thistactile biofeedback, along with the increasing resistance to furthermotion, may alert a patient to an overextension condition. Furthermore,because the prosthetic meniscus device 850 includes a gradual stoprather than an abrupt stop, the motion obtained by the prostheticmeniscus device 850 may be more consistent with the motion of a naturalmeniscus, where slightly elastic ligaments gradually tighten duringrotation to prevent over-rotation, instead of having an abrupt,inflexible stopping point. Accordingly, the vertical displacement may ofthe free floating meniscus component 852 may tactilely alert the patientto overextension giving the patient an opportunity to correct the kneeto alleviate the tension generated by the vertical displacement. Sodoing may enable the patient to avoid inadvertent over displacement ofthe prosthetic meniscus device 850, which may help the patient avoidexpulsion of the prosthetic meniscus device 850 from the patient's knee.

Although shown with having both the free floating meniscus component 852and the rigid base component 854 having matching profiles or edges 874,876 at the anterior peripheral portions 858, 868, other implementationshave profiles or edges that do not match. In some implementations, therigid base component 854 may have a simple planar slope as its edge 876at its anterior peripheral portion 868. In other implementations, theanterior peripheral portion 858 of the free floating meniscus component852 may have a substantially vertical profile at the edge 874, and theanterior peripheral portion 868 of the rigid base component 854 may havea curved or sloped edge 876. In some implementations, the verticaldisplacement between height H1 and height H2 may be in the range of 1 mmto 12 mm. Other ranges, both larger and smaller, are also contemplated.

FIGS. 12 and 13 show an additional implementation of a prostheticmeniscus device, referenced herein by the numeral 900, disposed on aTibia T. The prosthetic meniscus device 900 includes the free floatingmeniscus component 102 and a rigid base component 904. The free floatingmeniscus component 102 may be similar to those described herein, andthose descriptions will not be repeated here. The rigid base component904 may include an outer portion 906 and a bottom portion 908, togetherforming a basin or opening for receiving the free floating meniscuscomponent 102. The outer portion 906 may be an outer wall structureextending about and forming an outer peripheral portion of the rigidbase component. Thus, the outer portion 906 forms the containment cavitythat limits the allowable translation distance of the free floatingmeniscus component 102. This implementation differs from other rigidbase components described herein because the outer portion 906 extendsonly partially about the bottom portion 908. The bottom portion 908 maybe a supporting floor structure. FIG. 12 shows the prosthetic meniscusdevice 900 disposed on a tibia for use. The rigid base component 904 mayinclude an anterior portion 910, a posterior portion 912, and lateralside portions 914. In the implementation shown, the outer portion 906extends about the anterior portion 910 and the posterior portion 912,but the lateral side portions 914 are devoid of the outer portion 906.Accordingly, the free floating meniscus component 102 may translate orrotate within the rigid base component 904. However, the rotation withinthe rigid base component 904 may be limited by the outer portion 906which maintains the free floating meniscus component 102 in the rigidbase component 904. At the same time, the lateral side portions 914being devoid of the outer portion 906 may permit natural lubricatingfluids to more easily enter the sliding interface between the freefloating meniscus component 102 and the rigid base component 904. Insome implementations, the lateral side portions 914 include an outerportion, but with the outer portion at the lateral side portions 914having a height lower than the height of the outer portion 906 that islocated at the anterior portion 910 and the posterior portion 912. Insome implementations, the outer portion 906 has a different height atthe anterior portion 910 than at the posterior portion 912. For example,in some implementations the outer portion 906 at the anterior portion910 has a height less than a height of the outer portion 906 at theposterior portion 912. Other arrangements are also contemplated. Theprosthetic meniscus device 900 may perform in the same manner describedwith reference to FIGS. 10A-10D.

FIG. 14 discloses a method 600 of implanting the prosthetic meniscusdevices according to an exemplary implementation. The method may beperformed, for example, with respect to any of the prosthetic meniscusdevices described herein. It is understood that additional steps can beprovided before, during, and after the steps of method 600, and thatsome of the steps described can be replaced or eliminated from themethod 600.

In some exemplary implementations, the method begins at 602, with ahealth care provider assembling the prosthetic meniscus device prior toimplantation in a patient. Accordingly, at 601, the health care providermay select a floating meniscus component from a plurality of floatingmeniscus components arranged to fit within a rigid base component. Thefloating meniscus component may be any of the floating meniscuscomponents described herein. As described above, in someimplementations, a health care provider may be presented with aplurality of floating meniscus components, with each having a particularprofile or contour that may match a particular bone structure. In someimplementations, the plurality of floating meniscus components may havesimilar contours, but may be sized differently to match different sizedpatients.

At 602, the health care provider may introduce the floating meniscuscomponent into a cavity of the rigid base component in a mannerpermitting the floating meniscus component to translate within the rigidbase component.

At 606, the health care provider may create an incision at a joint of apatient having damaged soft tissue in a manner known in the art. At 608,the health care provider may introduce the floating meniscus and rigidbase components between opposing tissue surfaces at a joint havingdamaged soft tissue without removing or penetrating bone tissue at thejoint. Accordingly, in some implementations, the health care providerdoes not carve, cut, or introduce screws, fins, or other anchors intothe adjacent bone. As such, the prosthetic meniscus device may be freefloating within the joint. That is, it may have the ability to move orslide laterally within the joint, and may have the ability to rotatewithin the joint. Flexion at the joint may cause the prosthetic meniscusdevice to translate or rotate. Accordingly, the prosthetic meniscusdevice is devoid of mechanical anchors and is arranged to interface withthe natural tibia plateau and the femoral surface.

At 610, the health care provider may position the floating meniscus andrigid base components so that the first tissue interface surfacereceives a portion of the first bone the second tissue interfacereceives a portion of the second bone structure. This may occur when thefirst tissue-interface surface of the floating meniscus component andthe second tissue interface surface of the rigid base component areshaped to fit contours of the adjacent bone structure. In someimplementations, this may include a simple concave surface shaped toreceive adjacent bone structure. In other implementations, the floatingmeniscus and rigid base components may be particularly shaped to match aparticular bone surface. For example, in some implementations thefloating meniscus component is shaped to match the contours of a femoralsurface. As such, the first tissue interface surface may receivecontours of the femoral bone. Likewise, in some implementations, therigid base component is shaped to match the contours of a natural tibiaplateau. As such, the second tissue interface surface may receivecontours of the tibia bone. In other implementations, the tissueinterface surfaces may not have specific contours, but may be shapedwith concavities or may be relatively planar.

At 612, the health care provider may close the incision withoutmechanically connecting the floating meniscus or rigid base componentsto the first or second bone structure. This may enable the prostheticmeniscus device to free float within the joint.

A variety of materials are suitable for use in making components, suchas components 102, 104, 852, 854, and 904 of prosthetic devicesdescribed herein. In one aspect, the flexible (non-rigid) componentforming, such as for example the free floating meniscus component or thesofter component is formed from a material that will yield/deform undernormal human loading while the rigid material generally does not deformunder normal human loading. An example combination may include aflexible component or layer including a material formed from apolycarbonate-urethane having a hardness value of about 3.0 to 9.0 N/mm²and the rigid material being formed of stainless steel material, oralternatively, a rigid polyurethane, such as COROTHANE polyurethane 75D,having a hardness in the range of about 45 N/mm² to 85 N/mm².

Medical grade polyurethane based materials suitable for use in theembodiments described include, but are not limited to, isolated or incombination, the materials described or mentioned in the followingparagraphs.

Bionate®, manufactured by DSM, a polycarbonate-urethane is among themost extensively tested biomaterials ever developed. Carbonate linkagesadjacent to hydrocarbon groups give this family of materials oxidativestability, making these polymers attractive in applications whereoxidation is a potential mode of degradation, such as in pacemakerleads, ventricular assist devices, catheters, stents, and many otherbiomedical devices. Polycarbonate urethanes were the first biomedicalpolyurethanes promoted for their biostability. Bionate®polycarbonate-urethane is a thermoplastic elastomer formed as thereaction product of a hydroxyl terminated polycarbonate, an aromaticdiisocyanate, and a low molecular weight glycol used as a chainextender. The results of extensive testing encompassing Histology,Carcinogenicity, Biostability, and Tripartite Biocompatibility Guidancefor Medical Devices verifies the cost effective material'sbiocompatibility.

Another group of suitable materials are copolymers of silicone withpolyurethanes as exemplified by PurSil™, a Silicone Polyether Urethaneand CarboSil™, a Silicone Polycarbonate Urethane. Silicones have longbeen known to be biostable and biocompatible in most implants, and alsofrequently have the low hardness and low modulus useful for many deviceapplications. Conventional silicone elastomers can have very highultimate elongations, but only low to moderate tensile strengths.Consequently, the toughness of most biomedical silicone elastomers isnot particularly high. Another disadvantage of conventional siliconeelastomers in device manufacturing is the need for cross-linking todevelop useful properties. Once cross-linked, the resulting thermosetsilicone cannot be re-dissolved or re-melted. In contrast, conventionalpolyurethane elastomers are generally thermoplastic with excellentphysical properties. Thermoplastic urethane elastomers (TPUs) combinehigh elongation and high tensile strength to form tough, albeit fairlyhigh-modulus elastomers. Aromatic polyether TPUs can have an excellentflex life, tensile strength exceeding 5000 psi, and ultimate elongationsgreater than 700 percent. These materials are often used forcontinuously flexing, chronic implants such as ventricular-assistdevices, intraaortic balloons, and artificial heart components. TPUs caneasily be processed by melting or dissolving the polymer to fabricate itinto useful shapes.

The prospect of combining the biocompatibility and biostability ofconventional silicone elastomers with the processability and toughnessof TPUs is an attractive approach to what would appear to be a nearlyideal biomaterial. For instance, in polycarbonate-based polyurethanes,silicone copolymerization has been shown to reduce hydrolyticdegradation of the carbonate linkage, whereas in polyether urethanes,the covalently bonded silicone seems to protect the polyether softsegment from oxidative degradation in vivo. DSM synthesizedsilicone-polyurethane copolymers by combining two previously reportedmethods: copolymerization of silicone (PSX) together with organic(non-silicone) soft segments into the polymer backbone, and the use ofsurface-modifying end groups to terminate the copolymer chains.

Other applicable materials include PurSil™ silicone-polyether-urethaneand CarboSil™ silicone-polycarbonate-urethane which are truethermoplastic copolymers containing silicone in the soft segment. Thesehigh-strength thermoplastic elastomers are prepared through a multi-stepbulk synthesis where polydimethylsiloxane (PSX) is incorporated into thepolymer soft segment with polytetramethyleneoxide (PTMO) (PurSil) or analiphatic, hydroxyl-terminated polycarbonate (CarboSil). The hardsegment consists of an aromatic diisocyanate, MDI, with low molecularweight glycol chain extender. The copolymer chains are then terminatedwith silicone (or other) Surface-Modifying End Groups. Aliphatic (AL)versions of these materials, with a hard segment synthesized from analiphatic diisocyanate, are also available.

Many of these silicone urethanes demonstrate desirable combinations ofphysical properties. For example, aromatic silicone polyetherurethaneshave a higher modulus at a given shore hardness than conventionalpolyether urethanes—the higher the silicone content, the higher themodulus (see PurSil Properties). Conversely, the aliphatic siliconepolyetherurethanes have a very low modulus and a high ultimateelongation typical of silicone homopolymers or even natural rubber (seePurSil AL Properties). These properties make these materials veryattractive as high-performance substitutes for conventional cross-linkedsilicone rubber. In both the PTMO and PC families, some polymers havetensile strengths three to five times higher than conventional siliconebiomaterials.

Further examples of suitable materials include Surface Modifying EndGroups (SMEs) which are surface-active oligomers covalently bonded tothe base polymer during synthesis. SMEs—which include silicone (S),sulfonate (SO), fluorocarbon (F), polyethylene oxide (P), andhydrocarbon (H) groups—control surface chemistry without compromisingthe bulk properties of the polymer. The result is that key surfaceproperties, such as thromboresistance, biostability, and abrasionresistance, are permanently enhanced without additional post-fabricationtreatments or topical coatings. This technology is applied to a widerange of DSM's polymers.

SMEs provide a series of base polymers that can achieve a desiredsurface chemistry without the use of additives. Polyurethanes preparedaccording to DSM's development process couple endgroups to the backbonepolymer during synthesis via a terminal isocyanate group, not a hardsegment. The added mobility of endgroups relative to the backbonefacilitates the formation of uniform overlayers by the surface-activeend blocks. The use of the surface active endgroups leaves the originalpolymer backbone intact so the polymer retains strength andprocessability. The fact that essentially all polymer chains carry thesurface-modifying moiety eliminates many of the potential problemsassociated with additives.

The SME approach also allows the incorporation of mixed endgroups into asingle polymer. For example, the combination of hydrophobic andhydrophilic endgroups gives the polymers amphipathic characteristics inwhich the hydrophobic versus hydrophilic balance may be easilycontrolled.

Other suitable materials, manufactured by CARDIOTECH CTE, includeChronoFlex® and Hydrothane™.

The ChronoFlex®, polycarbonate aromatic polyurethanes, family ofmedical-grade segmented biodurable polyurethane elastomers have beenspecifically developed by CardioTech International to overcome the invivo formation of stress-induced microfissures.

HydroThane™, hydrophilic thermoplastic polyurethanes, is a family ofsuper-absorbent, thermoplastic, polyurethane hydrogels ranging in watercontent from 5 to 25% by weight. HydroThane™ is offered as a clear resinin durometer hardness of 80 A and 93 Shore A. The outstandingcharacteristic of this family of materials is the ability to rapidlyabsorb water, high tensile strength, and high elongation. The result isa polymer having some lubricious characteristics, as well as beinginherently bacterial resistant due to their exceptionally high watercontent at the surface. HydroThane™ hydrophilic polyurethane resins arethermoplastic hydrogels, and can be extruded or molded by conventionalmeans. Traditional hydrogels on the other hand are thermosets anddifficult to process.

Additional suitable materials manufactured by THERMEDICS includeTecothante® (aromatic polyether-based polyurethane), Carbothane®(aliphatic polycarbonate-based polyurethane), Tecophilic® (high moistureabsorption aliphatic polyether-based polyurethane) and Tecoplast®(aromatic polyether-based polyurethane). Tecothane® is a family ofaromatic, polyether-based TPU's available over a wide range ofdurometers, colors, and radiopacifiers. One can expect Tecothane resinsto exhibit improved solvent resistance and biostability when comparedwith Tecoflex resins of equal durometers. Carbothane® is a family ofaliphatic, polycarbonate-based TPU's available over a wide range ofdurometers, colors and radiopacifiers. This type of TPU has beenreported to exhibit excellent oxidative stability, a property which mayequate to excellent long-term biostability. This family, like Tecoflex,is easy to process and does not yellow upon aging. Tecophilic® is afamily of aliphatic, polyether-based TPU's which have been speciallyformulated to absorb equilibrium water contents of up to 150% of theweight of dry resin.

Additional materials of interest include Tecogel, a new member to theTecophilic family, a hydrogel that can be formulated to absorbequilibrium water contents between 500% to 2000% of the weight of dryresin, and Tecoplast®, a family of aromatic, polyether-based TPU'sformulated to produce rugged injection molded components exhibiting highdurometers and heat deflection temperatures.

Additional potentially suitable materials include four families ofpolyurethanes, named Elast-Eon™, which are available from AorTechBiomaterials. In some implementations, the free floating meniscuscomponent may be formed of polyether ether ketone (PEEK),polyetherketoneketone (PEKK), polyethylene, and other polymers.

Elast-Eon™ 1, a Polyhexamethylene oxide (PFMO), aromatic polyurethane,is an improvement on conventional polyurethane in that it has a reducednumber of the susceptible chemical groups. Elast-Eon™ 2, a Siloxanebased macrodiol, aromatic polyurethane, incorporates siloxane unto thesoft segment. Elast-Eon™ 3, a Siloxane based macrodiol, modified hardsegment, aromatic polyurethane, is a variation of Elast-Eon™ 2 withfurther enhanced flexibility due to incorporation of siloxane into thehard segment. Elast-Eon™ 4 is a modified aromatic hard segmentpolyurethane.

Bayer Corporation also produces candidate materials. Texin 4210 andTexin 4215 are thermoplastic polyurethane/polycarbonate blends forinjection molding and extrusion. Texin 5250, 5286 and 5290 are aromaticpolyether-based medical grade materials with Shore D hardness ofapproximately 50, 86, and 90 respectively for injection molding andextrusion.

In some embodiments, the flexible (non-rigid) components of theprosthetic devices are a melt mold composite implant composed of twobiocompatible materials: DSM Bionate® Polycarbonate-Urethane (PCU), 80Shore A, matrix material and ultra high molecular weight polyethylene(UHMWPE) reinforcement material (Dyneema Purity). In some particularembodiments, a component of prosthetic device formed of PCU andreinforced circumferentially with DSM Dyneema® fibers results in adesirable distribution of loads on the underlying articulation surfacesof the components of the prosthetic device.

Although described in the context of a knee system, the prostheticdevices 100 and 1000 described above may be utilized for forming avariety of prosthetic devices. For example, in some instances thecomposite implants are utilized for knee joints (including meniscus andtotal knee joints), hip joints (including acetabular cups), shoulderjoints, elbow joints, finger joints, and other load and/or non-loadreceiving prosthetic devices.

In some implementations, the free floating meniscus component and therigid base component may be formed with a gradient between the soft andhard elements. This gradient may be achieved, in some implementations,using 3-D printing for manufacturing. That is, by 3-D printing one orboth of the free floating meniscus component and the rigid basecomponent, a hardness gradient may be generated.

It should be appreciated that in some instances the prosthetic meniscusdevices 100. 850, and 900 of the disclosure may be formed by otherprocesses than those described herein. These manufacturing processesinclude any suitable manufacturing method. For example, withoutlimitation any of the following manufacturing methods may be utilized:injection molding including inserting inserts; compression moldingincluding inserting inserts; injection-compression molding includinginserting inserts; compression molding of prefabricated elementspre-formed by any of the above methods including inserting inserts;spraying including inserting inserts; dipping including insertinginserts; machining from stocks or rods; machining from prefabricatedelements including inserting inserts; and/or any of the above methodswithout inserts. Further, it should be appreciated that in someembodiments the prosthetic devices of the disclosure are formed ofmedical grade materials other than those specifically identified above.In that regard, in some embodiments the prosthetic devices are formed ofany suitable medical grade material.

While the principles of the disclosure have been set forth using thespecific embodiments discussed above, no limitations should be impliedthereby. Any and all alterations or modifications to the describeddevices, instruments, and/or methods, as well as any further applicationof the principles of the disclosure that would be apparent to oneskilled in the art are encompassed by the disclosure even if notexplicitly discussed herein. It is also recognized that variousunforeseen or unanticipated alternatives, modifications, and variationsof the disclosure may be subsequently made by those skilled in the art.All such variations, modifications, and improvements that would beapparent to one skilled in the art to which the disclosure relates areencompassed by the following claims.

1. (canceled)
 2. A two-part joint replacement device for replacingdamaged soft joint tissue, the device comprising: a free floating softjoint tissue replacement component comprising: a first tissue-interfacesurface shaped to engage a first anatomical structure of a joint havinga damaged soft tissue; a first posterior peripheral portion; a firstanterior peripheral portion; and a first sliding interface; and a freefloating rigid base component comprising: a second tissue-interfacesurface shaped to engage a second anatomical structure of the joint; asecond posterior peripheral portion; a second anterior peripheralportion; and a second sliding interface configured to engage the firstsliding interface, wherein the rigid base component is sized to permittranslation of the soft joint tissue replacement component between thesecond posterior peripheral portion and the second anterior peripheralportion, and wherein the soft joint tissue replacement component furthercomprises: a first height when the soft joint tissue replacementcomponent is disposed at the second posterior peripheral portion; and asecond height when the soft joint tissue replacement component isdisposed at the second anterior peripheral portion.
 3. The two-partjoint replacement device of claim 2, wherein the first posteriorperipheral portion includes a first vertical peripheral edge.
 4. Thetwo-part joint replacement device of claim 3, wherein the secondposterior peripheral portion of includes a second vertical peripheraledge.
 5. The two-part joint replacement device of claim 4, wherein thesoft joint tissue replacement component is configured to come to abrupthalt in the translation when the soft joint tissue replacement componentabuts the second posterior peripheral portion.
 6. The two-part jointreplacement device of claim 2, wherein the first anterior peripheralportion comprises a first curved or tapered edge.
 7. The two-part jointreplacement device of claim 6, wherein the second anterior peripheralportion comprises includes a second curved or tapered edge.
 8. Thetwo-part joint replacement device of claim 7, wherein the translation ofthe soft joint tissue replacement component along the second curved ortapered edge is configured to cause vertical displacement of the softjoint tissue replacement component from the first height to the secondheight.
 9. The two-part joint replacement device of claim 8, wherein thevertical displacement comprises a range between 1 mm and 12 mm.
 10. Thetwo-part joint replacement device of claim 8, wherein the first anteriorperipheral portion and the second anterior peripheral portion areconfigured to provide a gradual stop in the translation of the softjoint tissue replacement component.
 11. The two-part joint replacementdevice of claim 8, wherein the vertical displacement is configured toprovide tactile biofeedback.
 12. The two-part joint replacement deviceof claim 11, wherein the tactile biofeedback is configured to provide analert for over displacement of the soft joint tissue replacementcomponent.
 13. The two-part joint replacement device of claim 7, whereinthe second curved or tapered edge is disposed on an interior portion andan exterior portion of the rigid base component such that an exteriorprofile and an interior profile of the rigid base component match. 14.The two-part joint replacement device of claim 7, wherein the secondcurved or tapered edge is disposed only on an interior portion of therigid base component such that an exterior profile and an interiorprofile of the rigid base component do not match.
 15. The two-part jointreplacement device of claim 7, wherein a first profile of the firstanterior peripheral portion and a second profile of the second anteriorperipheral portion match.
 16. The two-part joint replacement device ofclaim 7, wherein a first profile of the first anterior peripheralportion and a second profile of the second anterior peripheral portiondo not match.